• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.34% Nasdaq Up0.85%

    GlaxoSmithKline plc (GSK)

    43.19 Up 0.34(0.80%) 2:06PM EST - Nasdaq Real Time Price
    Add to Portfolio
    ProfileGet Profile for:
    GlaxoSmithKline plc
    980 Great West Road
    Brentford, TW8 9GS
    United Kingdom - Map
    Phone: 44 20 8047 5000
    Website: http://www.gsk.com

    Index Membership:N/A
    Industry:Drug Manufacturers - Major
    Full Time Employees:99,451

    Business Summary 

    GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, such as vaccines, over-the-counter medicines, and health-related consumer products worldwide. The company provides pharmaceutical products in various therapeutic areas, such as respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, antibacterials, oncology and emesis, dermatology, rare diseases, immuno-inflammation, vaccines, and HIV. It also offers consumer health products in total wellness, oral care, nutritional, and skin health areas. The company's total wellness products comprise Panadol for the treatment of headache and joint pain, fever, and cold symptoms; NicoDerm, NiQuitin CQ, and Nicabate for the treatment of nicotine withdrawal as an aid to quitting smoking; and ENO Tums, a rapid relief antacid. Its oral care products include Sensodyne for the prevention of dental sensitivity; Polident, Poligrip, and Corega to enhance comfort of fitted dentures and to clean dentures; Aquafresh for the prevention of caries, gum disease, and bad breath; and Parodontax to help stop bleeding gums and gum health. The company’s nutrition products comprise Horlicks and Maxinutrition for nutrition; and skin health products include Physiogel, a face and body care product for dry, sensitive, and irritated skin, and Oilatum, a soothing treatment for eczema and dry skin conditions. In addition, it provides prescription medicines; and paediatric and adult vaccines against various infectious diseases. The company has a strategic cancer immunotherapy collaboration with Adaptimmune Limited to develop and commercialize NY-ESO-1 clinical cancer program. GlaxoSmithKline plc was founded in 1935 and is headquartered in Brentford, the United Kingdom.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on GlaxoSmithKline plc

    Key Executives 
    Sir Andrew Philip Witty , 49
    Chief Exec. Officer, Exec. Director, Member of Corp. Admin. & Transactions Committee and Member of Fin. Committee
    Mr. Simon Dingemans , 50
    Chief Financial Officer, Exec. Director, Member of Corp. Admin. & Transactions Committee and Member of Fin. Committee
    Dr. Moncef M. Slaoui Ph.D., 54
    Chairman of Global Vaccines, Exec. Director, Member of Corp. Admin. & Transactions Committee and Member of Fin. Committee
    Mr. Daniel E. Troy ,
    Sr. VP and Gen. Counsel
    Mr. Philip C. Thomson ,
    Sr. VP of Communications & Gov. Affairs
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.